NRG/RTOG 1112: randomized phase III study of sorafenib vs. stereotactic body radiation therapy (SBRT) followed by sorafenib in hepatocellular carcinoma (HCC) - Dawson, L A; Winter, K A; Knox, J J (JCO, 2023)